GSK to invest additional £ 140m at UK manufacturing sites

GlaxoSmithKline (GSK) is set to invest more than £ 140m at its production facilities in the UK to improve the efficiency and competitiveness of its manufacturing network.

Source: Pharmaceutical Technology - July 19, 2017 Category: Pharmaceuticals Source Type: news